News

AIMs activate the transcription factor Nrf2, that suppresses NF-?B, a transcription factor that is associated with chronic diseases such as multiple sclerosis, rheumatoid arthritis, chronic kidney disease, neurodegenerative

The new web-based technology is believed to help in effective research, where data will be translated into innovative products thereby bringing a growth in the economy, bdaily.co.uk reported.

The company will use the proceeds of the financing for the completion of its ongoing Phase II trial of the improved formulation of antidepressant TriRima, besides using it

Extracellular signal-regulated kinases (Erks) act in the Ras-Raf-Mek-Erk signaling cascade and regulate various cellular processes such as cell growth, proliferation and survival in response to a variety of

The company said Methscopolamine Bromide Tablets are AB rated to Pamine, a prescription medicine that is used as adjunctive therapy to treat peptic ulcers. Pamine is marketed by

MolecularMD has exclusively licensed the commercial rights to this property which covers methods for detecting the EGFR T790M mutation. The new patent describes methods of detecting the EGFR

The broad claims in the patent provide protection until 2028. The patent relates to a method of using recombinant C1 inhibitor (rhC1 INH), being produced either in cell

Daratumumab is a human CD38 monoclonal antibody with broad-spectrum killing activity and is in clinical development for multiple myeloma. This ongoing Phase I/II dose escalation study comprised 122

Under the agreement, a standardized testing protocol across the Acorn network of oncology community will be set up, providing treatment guidelines and clinical trial opportunities. The process is